These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8414522

  • 41. Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.
    Kuwabara T, Warashina M, Tanabe T, Tani K, Asano S, Taira K.
    Nucleic Acids Res; 1997 Aug 01; 25(15):3074-81. PubMed ID: 9224607
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Soda Y, Tani K, Bai Y, Saiki M, Chen M, Izawa K, Kobayashi S, Takahashi S, Uchimaru K, Kuwabara T, Warashina M, Tanabe T, Miyoshi H, Sugita K, Nakazawa S, Tojo A, Taira K, Asano S.
    Blood; 2004 Jul 15; 104(2):356-63. PubMed ID: 15039277
    [Abstract] [Full Text] [Related]

  • 47. Identification of a good c-myc antisense oligodeoxynucleotide target site and the inactivity at this site of novel NCH triplet--targeting ribozymes.
    Giles RV, Spiller DG, Clark RE, Tidd DM.
    Nucleosides Nucleotides; 1999 Sep 15; 18(9):1935-44. PubMed ID: 10549146
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.
    Halatsch ME, Schmidt U, Bötefür IC, Holland JF, Ohnuma T.
    J Neurosurg; 2000 Feb 15; 92(2):297-305. PubMed ID: 10659018
    [Abstract] [Full Text] [Related]

  • 52. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells.
    Hübinger G, Schmid M, Linortner S, Manegold A, Bergmann L, Maurer U.
    Exp Hematol; 2001 Oct 15; 29(10):1226-35. PubMed ID: 11602325
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Bcl-2 mRNA-targeted ribozymes: effects on programmed cell death in chronic myelogenous leukemia cell lines.
    Scheid S, Heinzinger M, Waller CF, Lange W.
    Ann Hematol; 1998 Oct 15; 76(3-4):117-25. PubMed ID: 9619728
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Investigating and improving the specificity of ribozymes directed against the bcr-abl translocation.
    James H, Mills K, Gibson I.
    Leukemia; 1996 Oct 15; 10(10):1676. PubMed ID: 8847909
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.